Search
forResearch 10 of 1000+
- Dermatologic adverse events associated with afatinib: an oral ErbB family blocker
- Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- Dermatologic Adverse Events from Cancer Treatments
- Dermatologic adverse events in EGFR-TKIs: A real-world analysis.
- Dermatological adverse events with taxane chemotherapy
- Evaluation of dermatologic adverse events associated with aromatase inhibitors: insights from the FAERS database
- Supportive Oncodermatology: Addressing dermatologic adverse events associated with oncologic therapies
- Predictive factors for adverse dermatological events during pegylated/interferon alpha and ribavirin treatment for hepatitis C
- Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force “Dermatology for Cancer Patients” International Study
Learn 1 of 20
All learn results →Community
— no results
Try a deeper search in community →